Pyrazine derivatives with extended conjugation and methods of using the same in optical applications

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9216963
APP PUB NO 20100233091A1
SERIAL NO

12305700

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to pyrazine derivatives capable of absorbing and emanating spectral energy in the visible and/or near infrared spectrum. Pyrazine derivatives of the invention may be administered to a patient in the form of a pharmaceutically acceptable composition and utilized in medical (e.g., diagnostic imaging) procedures.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDIBEACON LLC1100 CORPORATE SQUARE DRIVE HELIX CENTER UITE 229 ST LOUIS MO 63132

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dorshow, Richard B St. Louis, US 133 1773
Neumann, William L St. Louis, US 91 820
Rajagopalan, Raghavan Solon, US 162 2269

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 22, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00